On the afternoon of February 17, Professor Shi Yuanyuan, chairman of our company, was invited to the Institute of Biophysics of the Chinese Academy of Sciences to give an academic lecture on the topic of "Current Situation and Prospect of Cell Therapy". Academicians of the Chinese Academy of Sciences and the Academy of Sciences of Developing countries, Academician Wang Zhizhen, researcher of the Institute of Biophysics of the Chinese Academy of Sciences, project leader Jiang Tao, Yang Fuquan, Wang Likun, Wang Lei and other researchers, chief scientist of Shenzhen Cell Valley Professor Wang Jianxun and more than 100 teachers and students listened to the lecture hosted by Wang Lei, researcher of the State Key Laboratory of Biological Macromolecules.

First of all, Professor Shi Yuanyuan introduced the current situation of cell therapy industry and the advantages and disadvantages of cell products based on viral vector technology in the selection of viral vectors with the background of international and domestic cell therapy fields. It also analyzed and judged the poor treatment effect of cell therapy on solid tumors, the difficulty to control pre-treatment, the search and application of effective targets, the control of recurrence rate, and the control of side effects, and expressed its own views on the future development trend of cell therapy. His humorous and intelligent demeanor and eloquence were warmly praised by the teachers, students and guests present. Then in the question and answer session, Professor Shi Yuanyuan interacted with several teachers and students. The whole lecture lasted for 2 hours, and everyone was still interested.

Academician Wang Zhizhen, as Professor Shi Yuanyuan's doctoral supervisor at that time, made a speech, and highly recognized that Shenzhen Cell Valley, under the leadership of Chairman Shi Yuanyuan, could establish a cell therapy product industrialization team composed of scientists at home and abroad based on retroviral vector technology in a short period of time, and effectively solve the "neck" technical problems in the field of cell therapy in China. It is hoped that members of the Shenzhen Cell Valley team can uphold the spirit of science and pragmatism, devote themselves to the research and development of cell therapy technology and make contributions to the development of the national cell therapy field.

Institute of Biophysics, Chinese Academy of Sciences was founded in 1958, is the national Basic Research Institute of Life Sciences, its predecessor was Beijing Institute of Experimental Biology established in 1957.

By the end of 2019, the Institute had 14 academicians of the Chinese Academy of Sciences, 37 winners of the National Outstanding Youth Science Fund, 113 graduate supervisors (including 20 part-time), and a total of 1831 graduate students. There are 646 graduate students, including 435 doctoral students, 211 master's students and 6 foreign students. The Institute established a postdoctoral mobile station in 1987. The first-level disciplines are biology, and the second-level disciplines include biochemistry and molecular biology, cell biology, neurobiology, biophysics, etc. By the end of 2019, the Institute has a total of 66 postdoctoral fellows in the station.

As one of the leading research institutions in life science research in China, the strategic positioning of the Institute of Biophysics is: Give full play to the comprehensive advantages of multi-disciplines, achieve basic, forward-looking and strategic breakthroughs in the frontier fields of protein science, brain and cognitive science, infection and immunity, nucleic acid biology and other disciplines, strengthen the innovative development of key equipment in the field of life science, and achieve key breakthroughs in key technologies and experimental methods. Build a transformational research system focusing on biopharmaceutical and in vitro diagnostics, play a leading role in the source innovation and backbone of the national innovation system, continue to produce major leading scientific research achievements, and strive to enter the ranks of world-class research institutes in the field of life and health.